DesJardin Michael A. 4

4 · Horizon Therapeutics Public Ltd Co · Filed Jan 6, 2023

Form 4

Period: 2023-01-04

EVP, Technical Operations

Transactions

Exercise/Conversion
Ordinary Shares
2023-01-05+54,253→ 149,087 total
Award
Restricted Stock Units (RSUs)
2023-01-04+20,697→ 20,697 total
→ Ordinary Shares (20,697 underlying)
Exercise/Conversion
Restricted Stock Units (RSUs)
2023-01-05−12,095→ 0 total
→ Ordinary Shares (12,095 underlying)
Exercise/Conversion
Restricted Stock Units (RSUs)
2023-01-05−10,478→ 10,479 total
→ Ordinary Shares (10,478 underlying)
Exercise/Conversion
Restricted Stock Units (RSUs)
2023-01-05−7,141→ 14,283 total
→ Ordinary Shares (7,141 underlying)
Exercise/Conversion
Performance Restricted Stock Units (PSUs)
2023-01-05−7,257→ 0 total
→ Ordinary Shares (7,257 underlying)
Exercise/Conversion
Performance Restricted Stock Units (PSUs)
2023-01-05−1,966→ 0 total
→ Ordinary Shares (1,966 underlying)
Exercise/Conversion
Performance Restricted Stock Units (PSUs)
2023-01-05−4,834→ 0 total
→ Ordinary Shares (4,834 underlying)
Exercise/Conversion
Performance Restricted Stock Units (PSUs)
2023-01-05−10,482→ 5,236 total
→ Ordinary Shares (10,482 underlying)
Tax Payment
Ordinary Shares
2023-01-05$113.24/sh−26,901$3,046,269→ 122,186 total

Footnotes (7)

[F1]Each RSU/PSU represents a contingent right to receive one ordinary share of the Issuer.
[F2]The RSUs vest 1/3rd annually on each anniversary of January 5, 2023.
[F3]The final tranche of ordinary shares subject to the RSU vested on January 5, 2023.
[F4]The remaining ordinary shares subject to the RSU vest on January 5, 2024.
[F5]The remaining ordinary shares subject to the RSV vest ratably on January 5, 2024 and January 5, 2025.
[F6]The ordinary shares subject to the PSUs vested on January 5, 2023.
[F7]The remaining ordinary shares subject to the PSU vest on January 5, 2024.

Documents

1 file